Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
294.11
-4.20 (-1.41%)
At close: Mar 23, 2026, 4:00 PM EDT
299.99
+5.88 (2.00%)
After-hours: Mar 23, 2026, 5:13 PM EDT
PRAX Market Cap
PRAX has a market cap or net worth of $8.19 billion as of March 23, 2026. Its market cap has increased by 972.73% in one year.
Market Cap
8.19B
Enterprise Value
7.27B
1-Year Change
972.73%
Ranking
Category
Stock Price
$294.11
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.19B, an increase of 1,073.49%. That is a compound annual growth rate of 57.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 8.31B | 12.72% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 10.12B |
| ABIVAX Société Anonyme | 9.37B |
| ImmunityBio | 8.71B |
| Bio-Techne | 8.05B |
| Axsome Therapeutics | 8.03B |
| Arrowhead Pharmaceuticals | 7.89B |
| Vaxcyte | 7.88B |
| Cytokinetics | 7.60B |